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Species Differences in the Metabolism
and Disposition of Inhaled 1,3-Butadiene
and Isoprene
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Bond,* Rogene F. Henderson,* Joe L. Mauderly,*
Bruce A. Muggenburg,* James D. Sun,* and
Linda S. Birnbaumt
Speciesdifferences insensitivitytocarcinogenic effectsfrominhaled 1,3-butadiene mightstem, atleastin
part, fromdifferences inuptake, metabolism, anddistributionof1,3-butadiene. Toexaminethispossibility,
rats, mice, and monkeys were exposed to stepped concentrations of 14C-labeled 1,3-butadiene and the
chemically related compound, isoprene. Respiratory data were collected during exposure and were used to
determine fractional uptake. Rates and routes ofexcretion ofretained radioactivity were also determined
and blood levels of potentially toxic metabolites were measured. In some cases, the concentrations of
hemoglobin adducts were determined. For rodents, the tissue distribution of metabolites was examined.
Some results from these continuing studies to date are: a) mice achieve higher blood concentrations of
reactive metabolites than do rats; b) blood levels oftoxic metabolites are lower in monkeys than in rodents;
c)uptake andretention of1,3-butadiene isnonlinearintherangewherelong-termtoxicitystudieshavebeen
conducted; d) the efficiency of production of reactive metabolites decreases with increased inhaled con-
centrations of 1,3-butadiene; e) repeated exposure to 1,3-butadiene does not induce the metabolism of
1,3-butadiene inrodents; f)hemoglobin adductsof1,3-butadienearepotential dosimetersofexposure; andg)
rats inhaling isoprene produce reactive metabolites analogous to those produced during inhalation of
1,3-butadiene. The available data indicate that major differences in the biological fate of inhaled 1,3-bu-
tadieneoccuramongspecies, andthesedifferences, atleastinpart, accountforthoseinspeciessensitivityto
the toxicity of inhaled 1,3-butadiene.
Introduction
1,3-Butadiene is a major monomer in the rubber and
plastics industry, where there is potential worker ex-
posure. Incidences ofneoplasia are higher in this indus-
trythaninthegeneralpopulation. Ascertainingacausal
relationship between 1,3-butadiene exposure and the
increased neoplasia is complicated, however, because
thereisexposuretoawidevarietyofpotentiallyharmful
compounds in this industry, including several known
human carcinogens. Thus, the potential contribution of
1,3-butadiene tothe increased incidences cannotbe sep-
arated easily from the contributions ofother chemicals.
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The threshold limit value (TLV) for occupational ex-
posure to 1,3-butadiene had been set at 1000 ppm.
Therefore, the results of an oncogenesis study in
Sprague-Dawley rats (1) showing 1,3-butadiene to be a
weakcarcinogen at 8000 ppm over2 years did not cause
great concern. In that study, increased incidences of
mammary tumors, thyroid follicular adenomas, uterine
tumors, and exocrine pancreatic adenomas were noted.
The results of a more recent study sponsored by the
National Toxicology Program (NTP) (2), however,
caused more concern. There was marked increased inci-
dence ofprimary tumors in B6C3F1 mice in both sexes
exposedto625and 1250ppmforonly60to61weeks. The
study was stopped earlier than the originally planned 2
yearsbecause tumorsinthe exposed mice caused exces-
sive mortality. These murine tumors included lym-
phomas, hemangiosarcomas, alveolar/bronchiolar ade-
nomasandcarcinomas, acinarcellcarcinomas, granulosa
cell tumors, .forestomach tumors, and hepatocellular
adenomas and carcinomas. Thus, there was a great
difference insensitivitytothecarcinogenicity ofinhaledDAHL ET AL.
1,3-butadiene between mice and rats and also major
differences in the target tissues at risk.
The chemical disposition program of the NTP con-
ducts both prospective and retrospective studies that
will help design and interpret toxicity studies. The re-
sults of the two carcinogenicity studies with 1,3-bu-
tadiene raised the question of whether the observed
difference inspeciessensitivitycouldberelated, atleast
inpart, todifferencesinthedispositionofinhaled 1,3-bu-
tadiene between the two species. Could differences in
theabsorption, distribution, metabolism, orexcretionof
1,3-butadiene play a role in the species susceptibility to
1,3-butadiene carcinogenesis? In order to answer this
question, the disposition of inhaled 1,3-butadiene was
investigated.
Initialexperiments weredesigned a)todetermine the
uptake and retention of inhaled 14C-butadiene and the
retentionofitsmetabolitesbyratsandmiceoverarange
ofexposure concentrations, b) toidentifythe routes and
half-times forelimination oftheabsorbed 1,3-butadiene-
derived radioactivity, and c) to identify 1,3-butadiene
metabolites in the blood of both species. In addition,
studies were conducted to determine the distribution of
the 1,3-butadiene-derived radioactivity in tissues, as
well as the rates ofelimination ofthis material from the
tissues. These initial comparative studies have been
extended to include studies ofthe absorption, metabo-
lism, and elimination of inhaled 1,3-butadiene from cy-
nomolgus monkeys. The production of active metabo-
lites, especiallythose that havebeen shownbyothers to
be genotoxic, were compared among the three species.
In addition to the uptake, retention, and disposition
studies, the potential of 1,3-butadiene metabolites to
form adducts with hemoglobin has been investigated.
Hemoglobin adducts have been proposed as markers of
exposure. The correlation of hemoglobin adduct levels
with 1,3-butadiene metabolites in the blood is being
established.
Because repeated exposure to a chemical may alter
the way that chemical is handled due to induction or
inhibition of metabolic enzymes, rats and mice were
exposedrepeatedly to 1,3-butadiene. Themetabolismof
1,3-butadiene was examinedintissuesfromtheexposed
animals and was compared to tissues from animals not
previously treated.
1,3-Butadiene is one of several related compounds
used in the rubber industry. Structurally related com-
pounds include isoprene (2-methyl-butadiene) and
chloroprene (2-chloro-butadiene). Isoprene, a mono-
meric unit of terpenes, has been detected as a normal
constituent ofhuman androdent exhaled air(3,4). Since
the acutetoxicityofisopreneis similarto 1,3-butadiene,
we have conducted toxicokinetic studies on the fate of
inhaled isoprene in rats and compared the results of
absorption, metabolism, andexcretiontothoseobtained
from studies of 1,3-butadiene. Metabolism by mice and
monkeysisalsobeinginvestigated, aswell asthegener-
ation of hemoglobin adducts.
Results from the inhalation studies of 1,3-butadiene
by rodents have been published (5-7), as have those
from studies on the inhalation ofisoprene by rats (8). A
major purpose of the present report is to compare the
results obtained using rodents with those from con-
tinuingstudies onthetoxicokinetics ofinhaled 1,3-buta-
diene and isoprene in monkeys.
Methods
1,3-[1-14C]Butadiene with a radiochemical purity of
> 99% was used. Rodents were exposed by the nose-
only mode. Respiratory data (breathing frequency and
tidal volume) were obtained for selected rodents during
exposure. The methods used for rodents have been
described (5,8), and these references should be con-
sultedforexperimentaldetails. Monkeys(Macacafasci-
cularis, 5-7 kg males) were also exposed by the nose-
only mode. Experimental details were the same as for
rodents except as noted below. The exposure system
used (Fig. 1)wasamodification ofonedescribedforrats
(9) except that, because radiolabeled 1,3-butadiene was
used, a gas chromatograph was not needed. Also, in-
stead ofa pump to draw airpast the monkey's nose, the
respiratory action ofthe monkey was used for this pur-
pose. Monkeys were anesthetized with pentobarbital
duringexposure. Before exposure, monkeyswere fitted
withanarterialcatheterthatwasusedbothtointroduce
the anesthetic during exposure and to withdraw blood
samples. Respiratory data (breathing frequency and
tidal volume) for the monkey were obtained during
exposure as described previously (10). The exposure
protocols for rodents and monkeys are summarized in
Figure 2.
Results
The rate ofuptake ofbutadiene at approximately 10
ppm in mice was substantially greater than for rats or
monkeys when normalized to body weight (Table 1). A
greater rate of uptake for mice compared to rats was
observed forinhaled 1,3-butadiene concentrations rang-
FIGURE 1. System for exposing monkeys by the nose-only route to
vapors.
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FIGURE 2. Summary of exposure protocols for toxicokinetics of in-
haled 1,3-butadiene or isoprene in rodents and monkeys.
ing from 0.08 to 1000 ppm (Table 2). Data enabling the
inclusion of monkeys in this comparison are being ob-
tained in continuing exposures. Except for 1,3-bu-
tadiene at low inhaled concentrations (< 10 ppm) in
mice, retention of butadiene- and isoprene-introduced
14C after a 6-hr exposure was not proportional to the
concentration of inhalant (Fig. 3).
The route of elimination of 1,3-butadiene-introduced
14C after exposure of rodents was dependent to some
extent on the exposure concentration, but elimination
wasalwayslargelyviatheurine (Table3). Formonkeys,
elimination was mostly by CO2 exhalation after ex-
posure to 10 ppm 1,3-butadiene. The toxicological sig-
nificance ofthis observation is not clear; however, since
the initial metabolism of 1,3-butadiene probably in-
volves a mutagenic epoxide (11), whether or not CO2 is
the ultimate product (Fig. 4).
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FIGURE3. Efficiencyofretention of1,3-butadieneinratsandmiceand
ofisoprene in rats after 6-hr exposure to concentration from 0.01 to
10,000 ppm. The ordinate has been normalized to inhaled con-
centration in ppm and thus stands for efficiency ofuptake.
Total radioactivity in tissues after inhalation of 14C-
labeled 1,3-butadiene at700 ppmand 70 ppmbyratsand
mice, respectively, showedthat mousetissuescontained
15 to 100 times higher concentrations of 1,3-butadiene-
introduced 14C per ,umole ofinhaled 1,3-butadiene than
did rat tissues. Major differences in storage depots
Table 1. Uptake of 1,3-butadiene inhaled at approximately 10 ppm by mice, rats, and monkeys.a
1,3-Butadiene
Exposure Animal Retainednormalized
duration, meanmass, Inhaled Retained, to body mass,
Species hr kg ppm ,umole/hr/10 ppm ,umole/hr/10 ppm ,umole/hr/10 ppm/kg
Mouse 6 0.028 7.8 0.70 0.09 3.30
Rat 6 0.400 7.8 4.40 0.19 0.46
Monkey 2 6.200 10.0 16.40 3.20 0.52
aThe lastthreecolumns are normalized to 10 ppmand 1-hr exposure tofacilitate directcomparison among exposures ofdifferentconcentrations
and exposure durations.
Table 2. Inhaled dose of 1,3-butadiene in rats and mice inhaling
for 6 hr (mean SE).
Dose, p.mole/lkg
Exposure
concentration, ppm Rats Mice
0.08 0.08 0.01* 0.2 ± 0.02
0.78 0.3 0.01* 2 ± 0.2
7.2 2 0.1* 22 ± 4
72 40 3* 110 ± 11
1000 160 ±10* 650 ± 50
aDose is micromoles retained 6-hr postexposure.
*Significantly different (p < 0.05) from mice exposed to the same
1,3-butadiene concentration using Student's t-test.
between the species or increased asgociation of radio-
activity with target tissues was not observed (6).
The levels of potentially genotoxic materials in the
blood of mice inhaling approximately 10 ppm 1,3-bu-
tadiene was much higher than those in rats or monkeys
after2 hrofexposure (Table4). These metabolites were
tentatively identified, based on codistillation in vacuo
with standards. HPLC analysis of these metabolites
from monkey exhalant obtained during exposure to 10
ppm 1,3-butadiene showed coelution of > 10% with the
genotoxic monoepoxide of 1,3-butadiene.
In experiments to determine ifrepeated exposure to
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Table 3. Routes of elimination of metabolites of 1,3-butadiene after exposure (% of total metabolites eliminated in approximately
70-hr post-exposure) (mean + SE).
Species 1,3-Butadiene, ppm Exposure duration, hr Urine CO2 Feces
Monkey 10 2 39+ 5 56+ 9 0.8+0.6
Mouse 7.2 6 58+ 15 32+3 10 +2
78 6 79 + 15 5 + 1 16 + 2
1000 6 66 + 4 29 + 1 5 + 2
Rats 78 6 74 + 4 18 ±+5 8 + 2
1000 6 54 + 10 42 ± 1 4 ± 1
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FIGURE 4. Some possiblepathwaysformetabolismof1,3-butadiene to
carbon dioxide.
1,3-butadiene could induce 1,3-butadiene metabolism,
rats and mice were exposed to 7600 or 750 ppm of
butadiene, respectively, for 6 hr/day for 5 days (7). No
induction of1,3-butadiene metabolism was found in lung
or liver. In fact, repeated exposures resulted in an
approximate 50% depression of lung 1,3-butadiene
metabolism in both rats and mice.
Rats and mice were injected IP with 14C-labeled
1,3-butadiene in corn oil to determine levels of hemo-
globin adducts (12). The injected dose was distributed
over 2 or 3 days so that the daily dose was 100 ,umole/kg
bodyweight. Thisledtonearlylinearincreasesinadduct
levels with the injected dose. Single injected doses
greater than 100 ,umole/kg body weight did not give
linear responses, probably because of higher pro-
portional elimination of1,3-butadiene inthe exhalant for
largerinjected doses (Fig. 5). Becausethe 1,3-butadiene
for the method development work on the hemoglobin
adducts was IP, comparisons to tissue distribution of
1,3-butadiene metabolites after inhalation are not
warranted.
Isoprene (2-methyl-1,3-butadiene) undergoes metab-
olism to mutagenic products similar to those from
1,3-butadiene, namely, mono- and diepoxides (8). At
roughly comparable inhaled concentrations, blood levels
ofmutagenic metabolites in rats after inhalation of iso-
prene were higherthan afterinhalation of1,3-butadiene
(Table 5).
Table 4. Blood epoxide levels of rats, mice, and monkeys after
inhalation of 1,3-butadiene for 2 hr.
Exposure 1,3-butadiene Normalized blood epoxide,
Species concentration, ppm pmole/mL/ppm
Mouse 7.8 77
Monkey 10 0.13
Mouse 78 26
Rat 78 5.2
Summary and Conclusion
Some important results are summarized as follows: a)
Mice, whicharemore sensitivetothecarcinogenicactiv-
ity of 1,3-butadiene than are rats, achieve higher tissue
levelsofreactivemetabolitesthandoratsexposedtothe
same exposure concentration. b) Blood levels of toxic
metabolites (and probably hemoglobin adduct levels)
appear to be lower in monkeys after inhaling 1,3-bu-
tadienethanthey areineitherrodentspecies. c) Uptake
and retention of 1,3-butadiene is nonlinear in the range
where long-term toxicity studies have been conducted.
d) Although reactive metabolites are produced at all
exposure concentrations, the efficiency ofproduction of
these metabolites appears to decrease with increased
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FIGURE 5. Levels of 14C-butadiene metabolite adducts formed with
globininmice(A)orrats(0)24hrafterasingle IPinjection(lx, solid
lines)ofvariousamountsof'4C-butadienedissolvedincornoilortwo
(2x) or three'(3x) (dotted lines) daily injections of 100 ,umole 14C-
butadiene/kg body weight into mice (A) or rats (-). Data points are
means + SE (n = 3).
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Table 5. Blood concentrations of mutagens in rats after inhalation of isoprene or 1,3-butadiene, pmole/mL blood.a
Vapor Vaporconcentration, ppm Diepoxide" Epoxide Diepoxides/ppm Epoxides/ppm
Isoprene 8 500 63
260 10000 38
1480 21000 - 14
8200 23000 2.8
1,3-Butadiene 78 100 400 1.3 5.1
1000 1000 4000 1 4
'Assuming worst-case scenario wherein all radioactivity in blood that has volatility similar to the epoxide or diepoxide is that compound.
Volatilities were determined using cryogenic vacuum distillation (13).
concentrations of inhaled 1,3-butadiene. e) Repeated
exposures to 1,3-butadiene does not induce its metabo-
lism in either rats or mice.f) Hemoglobin adducts have
the potential to serve as dosimeters of exposure. Con-
tinuingresearch is directedtoward developing sensitive
chemicalmethodsfordetectingtheseadducts. g)Studies
with isoprene have revealed that metabolites analogous
to those produced from 1,3-butadiene are produced in
rats during exposure to isoprene. This has led to the
prediction that isoprene may have similar carcinogenic
properties to those observed for 1,3-butadiene. This
hypothesis is currently being tested in NTP-sponsored
studies.
Data from four studies are in substantial agreement
withthose ofLaib etal. (14) whoused different method-
ologies to examine 1,3-butadiene toxicokinetics. Taken
as a whole, the available data show important differ-
ences in the fate ofinhaled 1,3-butadiene among differ-
ent animal species. The direction of these differences
indicate they may explain, at least in part, the differ-
ences in sensitivity among species to the toxic effects of
inhaled 1,3-butadiene.
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